Gene · 7364
Papers2,547
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 2,547
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel molecular biomarkers of cancer therapy-induced cardiotoxicity in adult population: a scoping review. | ESC Heart Fail | 2022 | 35261178 | PubTator, text mining | PubMed |
| Gut microbiota induces high platelet response in patients with ST segment elevation myocardial infarction after ticagrelor treatment. | Elife | 2022 | 35258452 | PubTator, text mining | PubMed |
| The Blind Spot of Pharmacology: A Scoping Review of Drug Metabolism in Prematurely Born Children. | Front Pharmacol | 2022 | 35242037 | PubTator, text mining | PubMed |
| Effects of cytochrome P450 2B6 and constitutive androstane receptor genetic variation on Efavirenz plasma concentrations among HIV patients in Kenya. | PLoS One | 2022 | 35235559 | PubTator, text mining | PubMed |
| The Potential Application of Extracellular Vesicles from Liquid Biopsies for Determination of Pharmacogene Expression. | Pharmaceuticals (Basel) | 2022 | 35215364 | PubTator, text mining | PubMed |
| Pharmacokinetics and Bioequivalence of Two Empagliflozin, with Evaluation in Healthy Jordanian Subjects under Fasting and Fed Conditions. | Pharmaceuticals (Basel) | 2022 | 35215305 | PubTator, text mining | PubMed |
| Dabigatran Acylglucuronide, the Major Metabolite of Dabigatran, Shows a Weaker Anticoagulant Effect than Dabigatran. | Pharmaceutics | 2022 | 35213990 | PubTator, text mining | PubMed |
| Pharmacogenetics to Avoid Adverse Drug Reactions. | J Pers Med | 2022 | 35207648 | PubTator, text mining | PubMed |
| Classification of Breast Cancer Nottingham Prognostic Index Using High-Dimensional Embedding and Residual Neural Network. | Cancers (Basel) | 2022 | 35205681 | PubTator, text mining | PubMed |
| Exploring the Interactome of Cytochrome P450 2E1 in Human Liver Microsomes with Chemical Crosslinking Mass Spectrometry. | Biomolecules | 2022 | 35204686 | PubTator, text mining | PubMed |
| Genotypic and phenotypic landscapes of 51 pharmacogenes derived from whole-genome sequencing in a Thai population. | PLoS One | 2022 | 35176049 | PubTator, text mining | PubMed |
| Drug Disposition Protein Quantification in Matched Human Jejunum and Liver From Donors With Obesity. | Clin Pharmacol Ther | 2022 | 35158408 | PubTator, text mining | PubMed |
| Genetic Analysis of CYP2C9 with Reference to Drug Response in Epilepsy Patients of Pakistan. | Genet Res (Camb) | 2022 | 35136381 | PubTator, text mining | PubMed |
| Transport and metabolism of tyrosine kinase inhibitors associated with chronic myeloid leukemia therapy: a review. | Mol Cell Biochem | 2022 | 35129779 | PubTator, text mining | PubMed |
| Genetic and Clinical Factors Associated with Opioid Response in Chinese Han Patients with Cancer Pain: An Exploratory Cross-Sectional Study. | Pain Ther | 2022 | 35107781 | PubTator, text mining | PubMed |
| Identification of Potential Biological Factors Affecting the Treatment of Ticagrelor After Percutaneous Coronary Intervention in the Chinese Population. | Pharmgenomics Pers Med | 2022 | 35082514 | PubTator, text mining | PubMed |
| Comparison between Heat-Clearing Medicine and Antirheumatic Medicine in Treatment of Gastric Cancer Based on Network Pharmacology, Molecular Docking, and Tumor Immune Infiltration Analysis. | Evid Based Complement Alternat Med | 2022 | 35069767 | PubTator, text mining | PubMed |
| Potential interactions among myricetin and dietary flavonols through the inhibition of human UDP-glucuronosyltransferase in vitro. | Toxicol Lett | 2022 | 35063619 | PubTator, text mining | PubMed |
| A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation. | BMC Mol Cell Biol | 2022 | 35062878 | PubTator, text mining | PubMed |
| Computer-Aided Drug Design (CADD) to De-Orphanize Marine Molecules: Finding Potential Therapeutic Agents for Neurodegenerative and Cardiovascular Diseases. | Mar Drugs | 2022 | 35049908 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7364/papers?page=24